Other Stories

Full Video

Pfizer applies for emergency use authorization of COVID-19 vaccines for children aged 5 to 11 Updated: 2021-10-08 08:02:45 KST

Pfizer has requested emergency use authorization for its COVID-19 vaccines for children aged 5 to 11.
Pfizer on Thursday said it has seen a spike in new cases among children in the U.S.
The company revealed last month that its vaccine induced a strong immune response among 5 to 11 year olds in their clinical trials.
The FDA has said its will discuss Pfizer's application on October 26th.
Pfizer has already won emergency use authorization to inoculate teens aged 12 to 15.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.
weather